Huons recalls three injectable exports in US over cGMP compliance issue - CHOSUNBIZ - Chosunbiz
Huons recalls three injectable products in the US due to cGMP compliance issues, affecting their availability.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All pharmaceutical manufacturers involved with Huons' injectable products. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate action required as the recall is already in effect.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Recall of three injectable exports due to non-compliance with current Good Manufacturing Practices (cGMP).
Who it affects
All pharmaceutical manufacturers involved with Huons' injectable products.
What you must do
Review inventory for affected products and prepare for potential returns or replacements.
Deadline
Immediate action required as the recall is already in effect.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels - spencerfane.com
- New Hampshire Expands ‘Right to Try,’ Boosting Experimental Treatment Access - Governing
- The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year - ProPublica
- Nevada’s Proposed New Regulations: What Pharmacies Need to Know - bipc.com
- Title V Synthetic Minor Permit Applications: STA Pharmaceutical - dnrec.delaware.gov